Production of Dermatophagoides farinae Having Low Bacterial Content Using Ampicillin

Ju Yeong Kim1,2, Myung-Hee Yi1,2, Myungjun Kim1

  • 1Department of Environmental Medical Biology, Institute of Tropical Medicine and Arthropods of Medical Importance Resource Bank, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.

PubMed
Abstract

Insights

Ampicillin treatment significantly reduced bacteria and lipopolysaccharides in house dust mites for over 18 weeks. This approach helps develop safer allergy immunotherapy agents by controlling mite-associated immune responses.

Area of Science:

  • Immunology
  • Microbiology
  • Allergy Research

Background:

  • Symbiotic bacteria in house dust mites can cause immunological side effects during immunotherapy.
  • Investigating the impact of antibiotic treatment on mite bacterial load and allergenicity is crucial for clinical applications.

Purpose of the Study:

  • To determine the duration of bacterial reduction in Dermatophagoides farinae using ampicillin.
  • To assess if ampicillin treatment alters the allergenic properties of D. farinae.

Main Methods:

  • Dermatophagoides farinae was cultured with ampicillin, followed by subcultures without the antibiotic.
  • Bacterial counts, lipopolysaccharides (LPS), and major allergens (Der f 1, Der f 2) were quantified.
  • Human bronchial cells and a mouse asthma model were used to evaluate allergic airway inflammation.

Main Results:

  • Bacterial numbers and LPS levels decreased significantly for at least 18 weeks post-ampicillin treatment.
  • Ampicillin did not alter the concentrations of major allergens Der f 1 and Der f 2.
  • Reduced IL-6 and IL-8 secretion was observed, with no significant differences in lung function or inflammation in the mouse asthma model.

Conclusions:

  • Ampicillin treatment effectively reduces bacterial content in D. farinae, impacting immune response induction.
  • This method offers a strategy for developing more controlled and potentially safer allergy immunotherapy agents.

Related Concept Videos

Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Production of Pharmaceuticals01:30

Production of Pharmaceuticals

Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
The Skin Microbiota01:27

The Skin Microbiota

The human skin serves as a complex ecosystem inhabited by a diverse community of microorganisms, including bacteria, fungi, and viruses. This microbiome plays a critical role in maintaining skin health and defending against pathogenic invaders. The composition of microbial communities varies significantly across different regions of the body, influenced primarily by the local levels of moisture and sebum.Regional Variation in Skin MicrobiotaCutibacterium acnes predominantly colonizes sebaceous...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...